Abstract 922: End-to-end discovery to support the development of safe and efficacious engineered cell therapies

Authors: Katherine Vousden, Sanne Holt, Sophie Vermond, Monique Hazenoot, Sarah Ives, Sawsan Youssef, Jake Glanville

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-922

Source: Full article